SCHEMBL6501156

SCHEMBL6501156

NC(CO)(CO)CCc1cccc(-c2ccc(OCc3ccccc3)c(Cl)c2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 5/20 0.52
S1PR3 Q99500 2/20 0.52
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
NFKB1 P19838 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
MRGPRX4 Q96LA9 7/20 0.43
KMO O15229 1/20 0.42
HPGD P15428 1/20 0.42
PTGER1 P34995 1/20 0.42
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
XBP1 P17861 1/20 0.41
HTT P42858 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MGAM O43451 1/20 0.40
GAA P10253 1/20 0.40
SI P14410 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6527719 0.84 S1PR1 (0.65) S1PR1S1PR3SMN1; SMN2
SCHEMBL6508260 0.84 S1PR1 (0.61) S1PR1S1PR3SMN1; SMN2
SCHEMBL6507062 0.83 S1PR1 (0.60) S1PR1S1PR3SMN1; SMN2
Hydrochloric Acid SCHEMBL27894793 0.80 S1PR1 (0.65) S1PR1S1PR3MRGPRX4
SCHEMBL9617400 0.78 NPC1 (0.56) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL6504951 0.76 F9 (0.50) S1PR1S1PR3NPC1RAB9A
SCHEMBL6529129 0.74 S1PR1 (0.78) S1PR1S1PR3SMN1; SMN2
Hydrochloric Acid SCHEMBL6507340 0.73 S1PR1 (0.76) S1PR1S1PR3SMN1; SMN2
SCHEMBL86423 0.72 S1PR1 (0.57) S1PR1S1PR3SMN1; SMN2MRGPRX4
SCHEMBL86590 0.72 S1PR1 (0.66) S1PR1S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005014525-A2 BI-ARYL COMPOUND HAVING IMMUNOSUPPRESSIVE ACTIVITY MITSUBISHI PHARMA CORPORATION (JP) 2005-02-17 WO claimed
WO-2005014525-A2 BI-ARYL COMPOUND HAVING IMMUNOSUPPRESSIVE ACTIVITY MITSUBISHI PHARMA CORPORATION (JP) 2005-02-17 WO disclosed